Q4 2019 13F Holders as of 12/31/2019
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
363M
-
Number of holders
-
106
-
Total 13F shares, excl. options
-
107M
-
Shares change
-
+4.76M
-
Total reported value, excl. options
-
$443M
-
Value change
-
+$21M
-
Put/Call ratio
-
0.59
-
Number of buys
-
52
-
Number of sells
-
-39
-
Price
-
$4.15
Significant Holders of LEXICON PHARMACEUTICALS, INC. - COMMON STOCK (LXRX) as of Q4 2019
129 filings reported holding LXRX - LEXICON PHARMACEUTICALS, INC. - COMMON STOCK as of Q4 2019.
LEXICON PHARMACEUTICALS, INC. - COMMON STOCK (LXRX) has 106 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 107M shares
of 363M outstanding shares and own 29.38% of the company stock.
Largest 10 shareholders include Artal Group S.A. (60.2M shares), FMR LLC (12.6M shares), Ulys, L.L.C. (4.32M shares), BlackRock Inc. (4.05M shares), VANGUARD GROUP INC (2.98M shares), BOXER CAPITAL, LLC (2.78M shares), NEA Management Company, LLC (2.38M shares), MILLENNIUM MANAGEMENT LLC (1.31M shares), RENAISSANCE TECHNOLOGIES LLC (1.2M shares), and UBS ASSET MANAGEMENT AMERICAS INC (1.11M shares).
This table shows the top 106 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.